JCM
MD icon

JS Capital Management’s Pediatrix Medical MD Stock Holding History

JS Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-32,200
Closed -$551K – 197
2020
Q2 		$551K Buy
+32,200
New +$477K 0.04% 57
2020
Q1 		– Sell
-19,100
Closed -$531K – 170
2019
Q4 		$531K Buy
+19,100
New +$479K 0.06% 55

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

JS Capital Management's MD Position: Q3 2020 in Review

JS Capital Management sold out of Pediatrix Medical (MD) in Q3 2020, closing a stake of 32,200 shares — an estimated $551K sold.

JS Capital Management first reported a position in MD in Q4 2019 and held it in 2 quarters. The position peaked at $551K in Q2 2020. 207 funds tracked by Wall St. Rank hold MD as of Q3 2020.

  • JS Capital Management reported no remaining Pediatrix Medical position as of Q3 2020 after selling out during the quarter.
  • JS Capital Management sold 32,200 Pediatrix Medical shares in Q3 2020, an estimated $551K.
  • JS Capital Management first reported a position in Pediatrix Medical in Q4 2019 and held it in 2 quarters.
  • JS Capital Management's Pediatrix Medical position peaked at $551K in Q2 2020.
  • 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2020.

Based on JS Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.